People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TuHURA Biosciences, Inc./NV | — | Biotechnology | Series B | $41.6M | $6.1M | 2020 |
| Organovo Holdings, Inc. | — | Biotechnology | Series A | $24.0M | $277.0M | 2012 |
| Organovo, Inc. | — | Biotechnology | Seed | $5.0M | $155.0M | 2011 |
| Viscient Bio, Inc. | — | Biotechnology | Pre-Seed | $1.0M | $26.7M | 2021 |
Keith Murphy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Keith Murphy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andras Forgacs | 2 | 4 |
| Sharon Collins Presnell | 2 | 2 |
| Dennis Brown | 1 | 5 |
| Robert Hoffman | 1 | 5 |
| James Bianco | 1 | 4 |
| George Ng | 1 | 4 |
| Adam K Stern | 1 | 4 |
| James Manuso | 1 | 4 |
| SAIID ZARRABIAN | 1 | 3 |
| Gabor Forgacs | 1 | 3 |
| Jeffrey Bacha | 1 | 2 |
| Barry Michaels | 1 | 2 |
| Robert Baltera | 1 | 2 |
| Dan Dearborn | 1 | 2 |
| John K. Bell | 1 | 2 |
| Alan List | 1 | 2 |
| Laura Johnson | 1 | 2 |
| WILLIAM GARNER | 1 | 2 |
| Andras D. Forgacs | 1 | 1 |
| Barry D. Michaels | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.